E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 4
14 / 4Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research

Online Publishing Date:
15 / 05 / 2023

 


Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital

Bindu J Jadeja, Neeta Khokhar, Gaurishanker Shrimali.


Abstract
Background: Urinary tract infection (UTI) is a common health problem in both community and nosocomial settings. However, the predisposing factors which are responsible for production of extended spectrum beta-lactamase (ESBL) and carbapenem-resistant Enterobacteriaceae makes the treatment option narrow and cause multidrug resistance.

Aim and Objectives: This study demonstrate various risk factors associated with multidrug resistance in Enterobacteriaceae from UTI at tertiary care center in Gujarat.

Material and Methods: A retrospective observational study was conducted at a tertiary-care hospital. Urine samples were received from various departments and outpatient department (OPD). Organisms from Enterobacteriaceae group were isolated and identified by various biochemical methods. ESBL and Carbapenemase producing organisms were then processed for Antibiotic susceptibility test as per CLSI guideline.

Results: A total of 196 Enterobacteriaceae organisms were isolated from processed urine samples of tertiary care Hospitals. The most prevalent in people aged 45–65 years (36%) followed by those aged 17–30 (22%) years. UTI due to ESBL and Carbapenemase producer are more isolated in female (28%, 11%) as compare to male (16%, 6%). Indoor patients had higher prevalence of ESBL (29%) and carbapenemases (10%) isolation compare to OPD patient (ESBL-15%, Carbapenemases-7%) and among them most common ward was medicine department. The most common predisposing factor was catheterization followed by diabetes mellitus and obstructive uropathy.

Conclusion: High prevalence of ESBL and Carbapenemase producing Enterobacteriaceae is found in Indoor patients than OPD patients. Most of these patients are from Medicine department. Catheterization is the most common risk factor associated with ESBL and carbapenemase producing organism.

Key words: Enterobacteriaceae; Extended Spectrum Beta-Lactamase; Carbapenem-Resistant Enterobacteriaceae; Urinary Tract Infection


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Bindu J Jadeja
Articles by Neeta Khokhar
Articles by Gaurishanker Shrimali
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Jadeja BJ, Khokhar N, Shrimali G. Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2023; 13(6): 1304-1307. doi:10.5455/njppp.2023.13.04212202302052023

Web Style

Jadeja BJ, Khokhar N, Shrimali G. Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. https://www.njppp.com/?mno=150228 [Access: March 14, 2024]. doi:10.5455/njppp.2023.13.04212202302052023

AMA (American Medical Association) Style

Jadeja BJ, Khokhar N, Shrimali G. Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2023; 13(6): 1304-1307. doi:10.5455/njppp.2023.13.04212202302052023


Vancouver/ICMJE Style

Jadeja BJ, Khokhar N, Shrimali G. Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2023), [cited March 14, 2024]; 13(6): 1304-1307. doi:10.5455/njppp.2023.13.04212202302052023


Harvard Style

Jadeja, B. J., Khokhar, . N. & Shrimali, . G. (2023) Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. Natl J Physiol Pharm Pharmacol, 13 (6), 1304-1307. doi:10.5455/njppp.2023.13.04212202302052023


Turabian Style

Jadeja, Bindu J, Neeta Khokhar, and Gaurishanker Shrimali. 2023. Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 13 (6), 1304-1307. doi:10.5455/njppp.2023.13.04212202302052023


Chicago Style

Jadeja, Bindu J, Neeta Khokhar, and Gaurishanker Shrimali. "Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 1304-1307. doi:10.5455/njppp.2023.13.04212202302052023


MLA (The Modern Language Association) Style

Jadeja, Bindu J, Neeta Khokhar, and Gaurishanker Shrimali. "Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 13.6 (2023), 1304-1307. Print. doi:10.5455/njppp.2023.13.04212202302052023


APA (American Psychological Association) Style

Jadeja, B. J., Khokhar, . N. & Shrimali, . G. (2023) Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 13 (6), 1304-1307. doi:10.5455/njppp.2023.13.04212202302052023


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

  National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Publisher

publishernjppp@gmail.com

 

Editorial query

editornjppp1@gmail.com

MOB - 8780040272